MISSISSAUGA, ON — October 29, 2025 — Leads & Copy — Cipher Pharmaceuticals Inc. (TSX: CPH) (OTCQX: CPHRF) will release its financial results for the third quarter of 2025 after market close on Thursday, November 6, 2025. A conference call will be held on Friday, November 7, 2025, at 8:30 a.m. ET to discuss the results and corporate developments.
Conference call dial-in numbers are 416-945-7677 or 888-699-1199. The replay can be accessed at 289-819-1450 or 888-660-6345 (Code: 24367#) until November 14, 2025. A webcast will be available at https://app.webinar.net/gWN6RVqwnle.
Cipher Pharmaceuticals Inc. is a specialty pharmaceutical company with a diversified portfolio of commercial and early to late-stage products, mainly in dermatology. The company acquires products that fulfill unmet medical needs, manages clinical development, and markets products in Canada, the U.S., and South America.
Source: Cipher Pharmaceuticals Inc.
